![Christopher Wraight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christopher Wraight is the founder of Atisama Therapeutics Pty Ltd. Dr. Wraight was Chief Executive Officer at MecRx Pty Ltd. from 2017 to 2020.
Dr. Wraight was Chief Operating Officer at Otifex Therapeutics Pty Ltd. from 2011 to 2013.
Dr. Wraight was Research Director at Percheron Therapeutics Ltd. from 2003 to 2010.
Dr. Wraight completed undergraduate and doctorate degrees at La Trobe University in 1982.
Dr. Wraight earned an MBA from Chifley Business School.
Anciens postes connus de Christopher Wraight
| Sociétés | Poste | Fin |
|---|---|---|
MecRx Pty Ltd.
 MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Directeur Général | 01/01/2020 |
| PERCHERON THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | 31/08/2010 |
Rage Biotech Pty Ltd.
 Rage Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Directeur Général | 13/11/2025 |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Develops treatment for ear diseases | Directeur Général | - |
Formation de Christopher Wraight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Develops treatment for ear diseases | Health Technology |
Chifley Business School
 Chifley Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MecRx Pty Ltd.
MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Health Technology |
Rage Biotech Pty Ltd.
Rage Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Choisissez Zonebourse 
